Cargando…
Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications
[Image: see text] The binding processes of two Polo-like kinase inhibitors, RO3280 and GSK461364, to the human serum albumin (HSA) protein as well as the protonation equilibria of both compounds have been studied combining absorbance and fluorescence spectroscopy experiments together with density fu...
Autores principales: | Fernández-Sainz, Jesús, Pacheco-Liñán, Pedro J., Ripoll, Consuelo, González-Fuentes, Joaquín, Albaladejo, José, Bravo, Iván, Garzón-Ruiz, Andrés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997069/ https://www.ncbi.nlm.nih.gov/pubmed/36812406 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00849 |
Ejemplares similares
-
The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models
por: Pajtler, Kristian W, et al.
Publicado: (2016) -
Molecular Targeting of the Oncoprotein PLK1 in Pediatric Acute Myeloid Leukemia: RO3280, a Novel PLK1 Inhibitor, Induces Apoptosis in Leukemia Cells
por: Wang, Na-Na, et al.
Publicado: (2015) -
GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM)
por: Velpurisiva, Praveena, et al.
Publicado: (2018) -
Draft genome sequencing of the sugarcane hybrid SP80-3280
por: Riaño-Pachón, Diego Mauricio, et al.
Publicado: (2017) -
3280 Mycobacterium bovis Bacille-Calmette-Guérin infection aggravates atherosclerosis
por: Huaman, Moises, et al.
Publicado: (2019)